179 related articles for article (PubMed ID: 6299557)
21. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
Todaro B
J Natl Compr Canc Netw; 2012 Apr; 10(4):487-92. PubMed ID: 22491047
[TBL] [Abstract][Full Text] [Related]
22. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
[TBL] [Abstract][Full Text] [Related]
23. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
Ahmedzai S; Carlyle DL; Calder IT; Moran F
Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoids in the management of severe nausea and vomiting from cancer chemotherapy. Some additional considerations.
Garb S
J Clin Pharmacol; 1981; 21(S1):57S-59S. PubMed ID: 6271843
[TBL] [Abstract][Full Text] [Related]
25. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic treatment of chemotherapy-induced nausea and vomiting.
Fiore JJ; Gralla RJ
Cancer Invest; 1984; 2(5):351-61. PubMed ID: 6093949
[No Abstract] [Full Text] [Related]
27. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
Niiranen A; Mattson K
Am J Clin Oncol; 1985 Aug; 8(4):336-40. PubMed ID: 3002167
[TBL] [Abstract][Full Text] [Related]
28. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
Chow R; Valdez C; Chow N; Zhang D; Im J; Sodhi E; Lock M
Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
[TBL] [Abstract][Full Text] [Related]
29. An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
Priestman TJ; Priestman SG
Clin Radiol; 1984 Jul; 35(4):265-6. PubMed ID: 6329586
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy.
Wada JK; Bogdon DL; Gunnell JC; Hum GJ; Gota CH; Rieth TE
Cancer Treat Rev; 1982 Dec; 9 Suppl B():39-44. PubMed ID: 6299554
[No Abstract] [Full Text] [Related]
32. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
Chan HS; Correia JA; MacLeod SM
Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
[TBL] [Abstract][Full Text] [Related]
33. Nabilone and cancer chemotherapy.
Stark P
Ann Intern Med; 1982 Jan; 96(1):122. PubMed ID: 6274235
[No Abstract] [Full Text] [Related]
34. Nabilone in the management of prochlorperazine resistant cancer chemotherapy induced emesis.
Niamatali C; Fallon SD; Egan EL
Ir Med J; 1984 Sep; 77(9):276-7. PubMed ID: 6090342
[No Abstract] [Full Text] [Related]
35. Phase I-trial of clebopride, a new antiemetic, in chemotherapy--induced nausea and vomiting.
Lenz HJ; Schuler U; Hicking W; Ehninger G
Eur J Clin Pharmacol; 1990; 38(5):525. PubMed ID: 2379541
[No Abstract] [Full Text] [Related]
36. Antiemetic therapy for nausea and vomiting in the emergency department.
Patanwala AE; Amini R; Hays DP; Rosen P
J Emerg Med; 2010 Sep; 39(3):330-6. PubMed ID: 20022195
[TBL] [Abstract][Full Text] [Related]
37. The Safety of Prochlorperazine in Children: A Systematic Review and Meta-Analysis.
Lau Moon Lin M; Robinson PD; Flank J; Sung L; Dupuis LL
Drug Saf; 2016 Jun; 39(6):509-16. PubMed ID: 26884326
[TBL] [Abstract][Full Text] [Related]
38. Nabilone for the management of intractable nausea and vomiting in terminally staged AIDS.
Flynn J; Hanif N
J Palliat Care; 1992; 8(2):46-7. PubMed ID: 1321904
[No Abstract] [Full Text] [Related]
39. Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.
Niederle N; Schütte J; Schmidt CG
Klin Wochenschr; 1986 Apr; 64(8):362-5. PubMed ID: 3009962
[TBL] [Abstract][Full Text] [Related]
40. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
